Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05193149 · ClinicalTrials.gov registry record · NA

Inspiratory Muscle Training in Obese Breast Cancer Survivors

A NA study of Breast Cancer and Obesity, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT05193149 is a NA study of Breast Cancer and Obesity that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 78 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05193149, a NA study of Breast Cancer and Obesity, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.

Interventions

  • BEHAVIORAL Exercise training
  • BEHAVIORAL Inspiratory muscle training

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2023-11-13
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT05193149

The ClinicalTrials.gov registry entry for NCT05193149 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Exercise training is the first listed.

NCT05193149 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05193149 about?

NCT05193149 is a clinical study titled "Inspiratory Muscle Training in Obese Breast Cancer Survivors". The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.

What is the current status of trial NCT05193149?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2023-11-13. Estimated completion is 2026-06-30.

What conditions does trial NCT05193149 study?

This clinical trial studies the following conditions: Breast Cancer, Obesity, Cancer Survivors.

What interventions are being tested in trial NCT05193149?

The interventions under investigation include: Exercise training (BEHAVIORAL), Inspiratory muscle training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05193149?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05193149 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.